Sweta Gupta

Contributing Writer https://www.infectiousdiseaseadvisor.com

Sweta Gupta is a freelance writer and editor with more than 10 years of experience in media and publishing. She started her career at Wiley, editing textbooks on psychology, counseling, and social work. Afterward, she transitioned to working on professional content with Medscape Education, the largest US provider of continuing medical education programs. Most recently, she managed two websites for a clinician audience: Infectious Disease Advisor and Endocrinology Advisor. She is a graduate of Rutgers University and holds a BA in English literature and a minor in psychology.

All articles by Sweta Gupta

COVID19

Challenges in Assessing the Efficacy of COVID-19 Vaccines

Sweta Gupta

December 3, 2020

Study authors explored the challenges in assessing the efficacy of COVID-19 vaccines and discussed the caveats needed to interpret efficacy endpoints.

Doctor Showing Digital Tablet To Patient in ICU

COVID19

Remdesivir Superior to Placebo in Hospitalized Patients With COVID-19

Sweta Gupta

November 25, 2020

Researchers assessed if use of intravenous remdesivir in hospitalized patients with coronavirus disease 2019 infection affected time to recovery and clinical status on days 15 and 29.

Shedding Light on the Importance of HPV Vaccination

General Infectious Disease

Long-Term Immune Response With Single-Dose, Inactivated Japanese Encephalitis Vaccine

Sweta Gupta

November 16, 2020

Study authors investigated the persistence of immune response with a single-dose of inactivated Japanese encephalitis vaccine and the interchangeability with a live-attenuated vaccine in healthy children aged 1 to 15 years.

GI Illness

No Clinical Benefit With Double Anaerobic Therapy for Intra-Abdominal Infections

Sweta Gupta

November 11, 2020

Double anaerobic therapy with piperacillin/tazobactam plus metronidazole was compared to piperacillin/tazobactam alone to manage patients with intra-abdominal infections.

General Infectious Disease

Predictors of Acute Kidney Injury With Vancomycin OPAT

Sweta Gupta

November 9, 2020

The incidence of acute kidney injury in patients treated with vancomycin outpatient parenteral antimicrobial therapy was assessed, and risk factors for AKI in this population were identified.

COVID19

COALITION II Study: Adding Azithromycin to Severe COVID-19 Care With Hydroxychloroquine Does Not Improve Outcomes

Sweta Gupta

October 30, 2020

Study authors assessed whether azithromycin in addition to a hydroxychloroquine regimen shows positive results in clinical improvement or mortality reduction in patients hospitalized with severe COVID-19.

IDWeek 2020 HIV In-depth

People With HIV May Have a Higher Susceptibility to COVID-19

Sweta Gupta

October 28, 2020

Investigators compared the prevalence of HIV among patients hospitalized with COVID-19 compared to the general population and sought to determine whether patients with HIV had higher susceptibility to COVID-19.

IDWeek 2020 HIV In-depth

Rising Trend of Obstructive Sleep Apnea in the Aging HIV Population

Sweta Gupta

October 28, 2020

Investigators assessed the incidence of obstructive sleep apnea in patients with HIV and the comorbidities associated with increased incidence.

COVID19

Performance of 5 Immunoassays for SARS-CoV-2 Compared

Sweta Gupta

October 21, 2020

A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.

COVID19

Decrease in Antibodies to SARS-CoV-2 Seen Over 60 Days Among Health Care Personnel

Sweta Gupta

October 20, 2020

Investigators conducted a single-center study to evaluate the anti-SARS-CoV-2 antibodies at baseline and 60 days in health care personnel, who are at particular risk if antibodies level decline.

Next post in COVID19